Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Baxter
Boehringer Ingelheim
Chubb
McKesson
Accenture

Generated: May 22, 2019

DrugPatentWatch Database Preview

Drug Price Trends for DOXEPIN

« Back to Dashboard

Drug Price Trends for DOXEPIN

Average Pharmacy Cost for DOXEPIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DOXEPIN 75 MG CAPSULE 69238-1172-09 0.75707 EACH 2019-02-20
DOXEPIN 10 MG CAPSULE 00378-1049-01 0.31289 EACH 2019-02-20
DOXEPIN 10 MG CAPSULE 49884-0217-01 0.31289 EACH 2019-02-20
DOXEPIN 10 MG CAPSULE 51079-0436-01 0.31289 EACH 2019-02-20
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for DOXEPIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
SILENOR 3MG TAB Pernix Therapeutics LLC 42847-0103-30 30 65.28 2.17600 EACH 2018-05-01 - 2023-04-30 FSS
SILENOR 3MG TAB Pernix Therapeutics LLC 42847-0103-30 30 206.60 2019-01-01 - 2023-04-30 FSS
SILENOR 6MG TAB Pernix Therapeutics LLC 42847-0106-30 30 61.91 2.06367 EACH 2018-05-01 - 2023-04-30 FSS
SILENOR 6MG TAB Pernix Therapeutics LLC 42847-0106-30 30 206.60 2019-01-01 - 2023-04-30 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chinese Patent Office
Accenture
Chubb
Baxter
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.